If youre curious about options beyond semaglutide or tirzepatideor youve struggled with cost, side effects, or weight regainEast Carolina Weight Loss offers a safe, coaching-first, no-shots program built to reset metabolism and keep the weight off
In Phase II clinical trials in adults with overweight or obesity, once-daily orforglipron led to 9-15% mean weight loss at 36 weeks, with a GI tolerability profile typical of the class
Oxygen sensing optodes (Oyxylite, Oxford Optronix) were implanted in the ipsilateral ventral hippocampus at: (AP) 1.5, (ML) 0.8, (DV) 1.5 and in the contralateral pre-Btzinger complex at: (AP) 7.0, (ML) + 1.4, (DV) 4.1
Appetite shifts feel more organic and less forced
Orforgliprons Phase 3 ATTAIN-MAINTAIN trial specifically demonstrated that patients could successfully transition from injectable GLP-1s to orforglipron and maintain their weight loss